Orlando Immunology Center

Orlando, Florida, United States
Infectious disease physician in Orlando, Florida
1707 N Mills Ave, Orlando, FL 32803

About Orlando Immunology Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
60
Bristol-Myers Squibb
15
TaiMed Biologics Inc.
6
Community Research Initiative of New England
5
Alexion
4
Sangamo Therapeutics
4
Janssen Vaccines & Prevention B.V.
2
Myrexis Inc.
2
Orlando Immunology Center
2
University of Florida
2
Avexa
1
Total Rows: 28

Clinical Trials at Orlando Immunology Center


During the past decade, Orlando Immunology Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 41 clinical trials were completed, i.e. on average, 120.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8833663366223333771111444433554433Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
2003-07-01
2009-06-01
Completed
517
A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients
2005-05-01
Unknown status
32
TH9507 in Patients With HIV-Associated Lipodystrophy
2005-06-01
2007-04-01
Completed
412
Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation
2006-03-01
2007-10-01
Completed
20
Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
2006-04-01
2008-05-01
Completed
20
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
2006-05-01
2009-04-01
Completed
76
Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin
2006-10-01
2008-09-01
Completed
75
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
2006-12-18
2016-10-26
Completed
12,522

Rows per page:

1–100 of 120

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Orlando Immunology Center" #1 sponsor was "Gilead Sciences" with 60 trials, followed by "Bristol-Myers Squibb" with 15 trials sponsored, "TaiMed Biologics Inc." with 6 trials sponsored, "Community Research Initiative of New England" with 5 trials sponsored and "Alexion" with 5 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Immunology Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Westat" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 43 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 60Gilead Sciences: 60Bristol-Myers Squibb: 15Bristol-Myers Squibb: 15TaiMed Biologics Inc.: 6TaiMed Biologics Inc.: 6Community ResearchInitiative of NewEngland: 5Community ResearchInitiative of NewEngland: 5Alexion: 4Alexion: 4Sangamo Therapeutics: 4Sangamo Therapeutics: 4Janssen Vaccines &Prevention B.V.: 2Janssen Vaccines &Prevention B.V.: 2Myrexis Inc.: 2Myrexis Inc.: 2Orlando Immunology Center: 2Orlando Immunology Center: 2University of Florida: 2University of Florida: 2

Created with Highcharts 11.1.0Top CollaboratorsMerck Sharp & Dohme LLC: 5Merck Sharp & Dohme LLC: 5Westat: 3Westat: 3AbbVie: 2AbbVie: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2GlaxoSmithKline: 2GlaxoSmithKline: 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2Orlando Immunology Center: 2Orlando Immunology Center: 2Tibotec PharmaceuticalLimited: 2Tibotec PharmaceuticalLimited: 2ViiV Healthcare: 2ViiV Healthcare: 2ANRS, EmergingInfectious Diseases: 1ANRS, EmergingInfectious Diseases: 1

Clinical Trials Conditions at Orlando Immunology Center


According to Clinical.Site data, the most researched conditions in "Orlando Immunology Center" are "HIV Infections" (34 trials), "HIV-1 Infection" (16 trials), "HIV" (14 trials), "Hepatitis C" (13 trials) and "HIV-1-infection" (10 trials). Many other conditions were trialed in "Orlando Immunology Center" in a lesser frequency.

Clinical Trials Intervention Types at Orlando Immunology Center


Most popular intervention types in "Orlando Immunology Center" are "Drug" (106 trials), "Biological" (13 trials), "Device" (2 trials), "Genetic" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "RBV" (11 trials), "FTC/TDF" (9 trials), "Ribavirin" (9 trials), "E/C/F/TAF" (8 trials) and "Sofosbuvir" (8 trials). Other intervention names were less common.

Clinical Trials Genders at Orlando Immunology Center


The vast majority of trials in "Orlando Immunology Center" are 118 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Orlando Immunology Center


Currently, there are NaN active trials in "Orlando Immunology Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in Orlando Immunology Center, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Orlando Immunology Center, 14 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 51Phase 3: 51Phase 2: 44Phase 2: 44Phase 1: 14Phase 1: 14Phase 4: 9Phase 4: 9Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 98Completed: 98Active, not recruiting: 8Active, not recruiting: 8Terminated: 6Terminated: 6Recruiting: 4Recruiting: 4Unknown status: 2Unknown status: 2Enrolling by invitation: 1Enrolling by invitation: 1Withdrawn: 1Withdrawn: 1

Departments of Orlando Immunology Center


Orlando Immunology Center has several departments that took part in Clinical trials: "Orlando Immunology Center CRS" - 4 trials
Departments List
Name
City
Trials
Total Rows: 1